primari
system
vascul
psv
young
characteris
presenc
inflamm
wall
blood
vessel
result
tissu
ischaemia
necrosi
apart
rel
common
vasculitid
henochsch
onlein
purpura
hsp
kawasaki
diseas
kd
primari
vasculit
syndrom
rare
childhood
signific
attend
morbid
mortal
latest
develop
field
paediatr
vascul
includ
recent
consensu
confer
new
intern
classif
childhood
vasculitid
b
identif
variou
genet
polymorph
may
relev
term
diseas
predisposit
develop
diseas
complic
c
novel
therapeut
approach
includ
increas
use
biolog
case
current
standard
first
line
treatment
fail
induc
sustain
remiss
addit
increas
surviv
affect
patient
new
challeng
particularli
regard
longer
term
cardiovascular
morbid
children
surviv
vascul
loom
purpos
review
present
overview
primari
vasculitid
often
affect
children
review
recent
area
scientif
clinic
import
mani
year
need
accept
classif
childhood
vascul
far
much
relianc
adult
vascul
classif
system
definit
suboptim
paediatr
vasculitid
recent
intern
consensu
confer
held
vienna
june
auspic
pediatr
rheumatolog
european
societi
pre
result
new
propos
childhood
vascul
classif
summaris
tabl
criteria
current
valid
anticip
import
step
provid
fit
purpos
classif
system
use
futur
epidemiolog
studi
clinic
trial
paediatr
vascul
hsp
common
form
system
vascul
childhood
predominantli
affect
small
vessel
presenc
palpabl
purpura
absenc
thrombocytopenia
essenti
classif
criterion
epidemiolog
aetiolog
pathogenesi
although
adult
case
describ
hsp
typic
affect
children
age
year
case
occur
age
year
old
gardnermedwin
et
al
report
estim
annual
incid
per
children
uk
male
commonli
affect
particularli
autumn
winter
hsp
may
follow
intercurr
infect
upper
respiratori
tract
infect
although
caus
hsp
unknown
like
iga
pivot
role
pathogenesi
diseas
hypothesi
support
almost
univers
deposit
iga
lesion
vascular
tissu
serum
iga
level
increas
acut
phase
proport
patient
circul
igacontain
immun
complex
cryoglobulin
skin
renal
biopsi
demonstr
deposit
iga
mainli
wall
dermal
capillari
post
capillari
venul
mesangium
studi
found
iga
antineutrophil
cytoplasm
antibodi
igaanca
patient
hsp
whilst
other
shown
increas
igarheumatoid
factor
igaanticardiolipin
antibodi
recent
galactos
defici
olink
glycan
hing
region
report
adult
iga
nephropathi
children
hsp
aberrantli
glycosyl
protein
form
immun
complex
deposit
mesangium
bind
mesangi
cell
stimul
cellular
prolifer
overexpress
extracellular
matrix
compon
result
typic
renal
lesion
associ
hsp
iga
nephropathi
wide
varieti
infecti
agent
report
potenti
trigger
hsp
includ
group
betahaemolyt
streptococcu
ga
case
bartonella
hensela
parvoviru
staphylococcu
aureu
helicobact
pylori
haemophilu
parainfluenza
coxsaki
viru
amongst
other
regard
host
suscept
sever
genet
polymorph
relat
hsp
particular
sever
andor
risk
renal
involv
recent
describ
summaris
tabl
adapt
brogan
whole
studi
hsp
genet
hamper
rel
small
patient
number
thu
lack
power
definit
necessarili
applic
racial
group
peru
et
al
recent
describ
children
hsp
report
skin
involv
arthriti
gastrointestin
involv
renal
involv
palpabl
purpura
present
sign
patient
promin
lower
limb
buttock
local
angioedema
may
preced
develop
purpura
joint
involv
compris
symmetr
arthriti
typic
affect
ankl
feet
knee
common
gastrointestin
symptom
abdomin
pain
occasion
associ
vomit
bleed
intussuscept
seriou
acut
surgic
complic
occur
patient
perfor
usual
ileal
also
observ
albeit
minor
rarer
manifestast
includ
seros
chylou
ascit
acut
pancreat
renal
involv
usual
manifest
haematuria
develop
renal
diseas
occur
within
week
hsp
onset
hamdan
et
al
report
variat
incid
nephriti
accord
age
case
occur
children
less
year
age
children
year
age
risk
chronic
renal
failur
relat
initi
clinic
present
less
haematuria
andor
minim
proteinuria
nephrit
nephrot
syndrom
found
de
almeida
et
al
report
develop
signific
abdomin
pain
signific
predictor
nephriti
less
frequent
seriou
manifest
includ
cerebr
vascul
orchiti
ureter
pulmonari
haemorrhag
larg
major
case
hsp
requir
symptomat
treatment
arthropathi
manag
rest
analgesia
efficaci
corticosteroid
prevent
sever
complic
relaps
controversi
weiss
et
al
perform
metaanalysi
base
comprehens
review
literatur
medlin
databas
januari
cochran
control
trial
regist
basi
report
outcom
among
patient
hsp
treat
diagnosi
corticosteroid
compar
patient
treat
support
care
odd
ratio
calcul
resolut
abdomin
pain
need
surgic
intervent
secondari
sever
pain
intussuscept
likelihood
hsp
recurr
develop
transient
persist
renal
diseas
two
studi
analys
evalu
prospect
effect
corticosteroid
abdomin
pain
durat
use
day
symptom
diari
huber
seri
dose
mgkgday
prednisolon
week
wean
week
use
use
median
valu
total
abdomin
pain
durat
differ
found
treatment
control
group
contrast
ronkainen
et
al
studi
patient
randomis
receiv
prednisolon
mgkgday
week
wean
follow
week
report
signific
reduct
intens
durat
abdomin
pain
conflict
result
studi
examin
role
preemptiv
corticosteroid
prevent
develop
nephriti
time
write
review
suggest
current
consensu
opinion
corticosteroid
prevent
onset
nephriti
role
treatment
sever
nephriti
develop
regard
immunosuppress
therapi
cyclosporin
effect
retrospect
studi
hsp
nephriti
well
number
case
report
hsp
nephriticrang
proteinuria
other
suggest
good
respons
combin
therapi
steroid
azathioprin
cyclophophamid
plasma
exchang
intraven
immunoglobulin
effect
individu
case
paediatr
nephrologist
would
consid
use
angiotensin
convert
enzym
inhibitor
proteinuria
persist
month
limit
secondari
glomerular
injuri
major
children
hsp
make
full
unev
recoveri
evid
ongo
signific
renal
diseas
howev
hsp
nephriti
report
caus
esrf
children
uk
instanc
hypertens
report
mani
year
normalis
renal
function
urinalysi
increas
incid
preeclampsia
also
report
view
would
advoc
monitor
bp
minimum
year
normalis
urinari
sediment
although
lifelong
follow
annual
bp
urinalysi
gp
propos
children
hsp
unselect
popul
hsp
overal
risk
signific
longterm
renal
impair
around
children
isol
haematuria
proteinuria
neglig
incid
longterm
renal
morbid
patient
present
isol
microscop
andor
macroscop
haematuria
may
microscop
haematuria
persist
mani
month
year
recurr
episod
macroscop
haematuria
may
occur
follow
upper
respiratori
tract
infect
prognosi
gener
remain
good
unless
evid
signific
proteinuria
isol
haematuria
associ
proteinuria
risk
longterm
renal
dysfunct
around
children
present
acut
nephrit
syndrom
less
favour
outcom
longterm
risk
crf
mix
nephriticnephrot
present
worst
longterm
outlook
develop
crf
aggress
renal
biopsi
chang
like
poorer
longterm
outlook
children
signific
renal
impair
present
andor
persist
proteinuria
undergo
regular
assess
gfr
eg
year
post
acut
episod
hsp
major
children
hsp
make
full
unev
recoveri
howev
hsp
nephriti
report
caus
esrf
children
uk
steroid
role
treatment
sever
abdomin
pain
hsp
intussuscept
exclud
corticosteroid
prevent
onset
nephriti
role
treatment
sever
nephriti
develop
kawasaki
diseas
kd
selflimit
vasculit
syndrom
predominantli
affect
medium
small
size
arteri
complic
develop
coronari
arteri
aneurysm
caa
untreat
patient
fall
treatment
sometim
system
arteri
injuri
occur
addit
caa
rare
seen
absenc
caa
kd
lead
caus
acquir
paediatr
heart
diseas
worldwid
caa
lead
myocardi
infarct
late
coronari
arteri
stenosi
approxim
children
kd
younger
five
year
old
patient
age
less
month
year
encount
less
commonli
increas
risk
coronari
arteri
aneurysm
format
higher
incid
note
amongst
japanes
children
estim
incid
children
age
less
five
year
doubl
last
decad
uk
current
report
increas
may
truli
indic
increas
incid
better
case
recognit
may
partli
account
rise
trend
hallmark
kd
arter
presenc
lesion
variou
stage
progress
within
patient
given
time
earliest
chang
observ
endothelium
musculoelast
arteri
advanc
lesion
show
edema
inflammatorycel
infiltr
subendotheli
space
chang
progress
destruct
media
replac
intima
media
fibrou
connect
tissu
thin
media
aneurysm
format
scar
stenosi
coronaryarteri
ruptur
extrem
rare
occur
subacut
phase
myointim
prolifer
stenosi
occur
period
month
year
lesion
may
remain
silent
moment
acut
thrombot
occlus
often
decad
acut
ill
great
challeng
still
remain
hunt
caus
kd
season
variat
kd
incid
report
outbreak
kd
link
weather
pattern
cluster
kd
case
occur
associ
precipit
addit
abrupt
onset
symptom
compat
infect
fairli
rapid
resolut
ill
week
even
without
treatment
usual
without
recurr
clinic
featur
kd
support
infecti
caus
recent
cytoplasm
inclus
antibodi
identifi
ciliat
bronchial
epithelium
children
fatal
acut
kd
lead
author
studi
suggest
viral
infect
caus
kd
howev
hunt
singl
infecti
agent
far
prove
fruit
fact
recent
highlight
neg
result
emerg
studi
examin
potenti
link
coronaviru
infect
kd
taiwan
hypothesi
bacteri
toxin
caus
kd
favour
investig
theori
base
clinic
immunolog
similar
kd
staphylococc
streptococc
toxinmedi
ill
recent
observ
children
kd
seroconvert
igm
antibodi
number
bacteri
superantigen
remain
area
controversi
howev
sever
polymorph
relat
kd
particular
diseas
suscept
andor
risk
coronari
arteri
aneurysm
develop
recent
describ
summaris
tabl
kd
acut
childhood
ill
usual
affect
previous
healthi
infant
children
diagnost
criteria
complet
incomplet
kd
creat
epidemiolog
survey
japan
list
diagnost
criteria
complet
kd
fever
least
day
durat
criteria
lack
anoth
known
diseas
process
explain
ill
bilater
nonpurul
conjunctiv
inject
limbic
spare
ii
chang
mucou
membran
upper
respiratori
tract
inject
fissur
lip
strawberri
tongu
iii
polymorph
rash
iv
chang
extrem
peripher
oedema
peripher
erythema
periungu
desquam
second
week
ill
v
cervic
adenopathi
howev
patient
fewer
princip
featur
symptom
diagnos
kd
coronari
aneurysm
dilat
recogn
echocardiographi
coronari
angiographi
irrit
import
sign
virtual
univers
present
although
includ
one
diagnost
criteria
exact
mechan
irrit
unclear
may
relat
presenc
asept
mening
anoth
clinic
sign
incorpor
diagnost
criteria
rel
specif
kd
develop
erythema
indur
site
bcg
immun
mechan
clinic
sign
cross
reactiv
cell
kd
patient
specif
epitop
mycobacteri
human
heat
shock
protein
increas
number
infant
receiv
bcg
uk
like
sign
becom
common
awar
could
result
earlier
diagnosi
treatment
import
point
worthi
emphasi
criteria
may
present
sequenti
call
incomplet
case
evolv
time
complet
case
thu
diagnosi
kd
must
consid
child
febril
exanthemat
ill
particularli
persist
longer
four
five
day
rel
common
clinic
find
kd
includ
arthriti
asept
mening
pneumon
uveiti
gastroenter
meatiti
dysuria
otiti
rel
uncommon
abnorm
includ
hydrop
gallbladd
gastrointestin
ischaemia
jaundic
petechi
rash
febril
convuls
encephalopathi
ataxia
cardiac
complic
coronari
arteri
abnorm
includ
cardiac
tamponad
cardiac
failur
myocard
pericard
addit
rare
complic
kd
includ
macrophag
activ
syndrom
syndrom
inappropri
antidiuret
hormon
secret
siadh
earli
recognit
treatment
kd
aspirin
ivig
shown
unequivoc
metaanalysi
reduc
occurr
caa
moreov
preval
coronari
arteri
abnorm
kd
highli
depend
total
ivig
dose
independ
aspirin
dose
treat
aspirin
alon
children
develop
caa
combin
therapi
aspirin
high
dose
ivig
given
singl
infus
reduc
occurr
caa
day
day
onset
ill
preval
caa
invers
relat
total
dose
ivig
gkg
ivig
optim
dose
usual
given
singl
infus
metaanalysi
randomis
control
trial
compar
divid
lower
dose
ivig
mgkgday
four
consecut
day
versu
singl
infus
high
dose
ivig
gkg
hour
clearli
shown
therapeut
benefit
prevent
caa
latter
regimen
one
import
practic
point
howev
infant
cardiac
compromis
may
abl
toler
fluid
challeng
associ
high
dose
singl
infus
consider
divid
dose
given
sever
day
may
appropri
patient
group
ivig
treatment
start
earli
diseas
prefer
within
first
day
ill
importantli
howev
clinician
hesit
give
ivig
patient
present
day
sign
persist
inflamm
patient
respond
singl
dose
ivig
requir
second
dose
observ
children
receiv
ivig
earli
ill
may
requir
second
infus
ivig
primari
treatment
failur
diseas
recrudesc
thu
time
ivig
administr
appear
import
although
latter
point
dissuad
clinician
give
ivig
day
fever
diagnosi
kd
suspect
one
question
remain
unansw
whether
type
ivig
administ
import
perhap
result
presenc
antibodi
epitop
deriv
differ
donor
pool
said
although
mechan
action
ivig
remain
unknown
recent
evid
suggest
efficaci
ivig
resid
within
fc
fragment
fab
compon
ivig
resist
occur
case
case
advoc
use
corticosteroid
albeit
appar
conflict
data
base
practic
inou
et
al
show
random
control
trial
kd
patient
assign
receiv
ivig
ivig
plu
corticosteroid
corticosteroid
regimen
use
studi
prednisolon
sodium
succin
mgkgday
time
daili
given
intraven
iv
inject
fever
resolv
oral
creactiv
protein
crp
level
normal
crp
normal
prednisolon
dose
taper
day
found
addit
corticosteroid
reduc
caa
receiv
convent
treatment
caa
one
month
compar
receiv
convent
treatment
plu
corticosteroid
contrast
newburg
et
al
subsequ
multicent
random
doubleblind
placebocontrol
trial
examin
effect
addit
singl
dose
intraven
methylprednisolon
standard
therapi
found
corticosteroid
regimen
improv
caa
outcom
children
contrast
result
suggest
dose
durat
corticosteroid
may
critic
adjunct
efficaci
kd
treatment
cyclophosphamid
cyclosporin
plasma
exchang
may
also
warrant
ongo
diseas
activ
despit
ivig
corticosteroid
recent
infliximab
report
effect
treatment
ivig
resist
kd
patient
cessat
fever
follow
reduct
crp
import
preliminari
observ
support
unpublish
observ
infliximab
efficaci
ivig
resist
kd
kd
emerg
common
caus
acquir
heart
diseas
children
develop
world
caa
remain
silent
third
even
fourth
decad
life
prognosi
better
aneurysm
small
mm
fusiform
overal
outlook
children
kd
good
acut
mortal
rate
due
myocardi
infarct
reduc
alert
clinician
diagnosi
prompt
treatment
nonetheless
diseas
may
eventu
contribut
burden
adult
cardiovascular
diseas
area
activ
ongo
research
function
polymorph
inositol
c
itpkc
gene
link
immun
activ
kd
genet
contribut
polygen
remain
fulli
defin
featur
kd
may
present
sequenti
sought
histori
well
examin
earli
recognit
treatment
kd
aspirin
ivig
shown
unequivoc
reduc
occurr
caa
ivig
administ
dose
gkg
usual
given
singl
infus
case
ivig
resist
use
corticosteroid
advoc
infliximab
may
also
effect
ivig
resist
kd
activ
studi
propos
new
classif
criteria
recognis
three
subtyp
polyarter
system
polyarter
nodosa
pan
cutan
polyarter
microscop
polyangi
system
pan
characteris
necrot
inflammatori
chang
medium
andor
small
size
arteri
diseas
rare
childhood
although
epidemiolog
poorli
defin
pan
occur
commonli
children
anca
associ
vasculitid
although
organ
affect
pan
commonli
involv
skin
joint
peripher
nerv
gastrointestin
gi
tract
kidney
diseas
manifest
divers
complex
rang
benign
cutan
form
sever
dissemin
multisystem
form
pan
also
observ
complic
hepat
b
viru
hbv
hepat
c
viru
hcv
infect
literatur
pan
often
describ
along
microscop
polyangi
mpa
latter
previous
refer
microscop
polyarter
accord
new
classif
criteria
childhood
vascul
pan
defin
vascul
caus
necrot
inflamm
mediums
smallsiz
arteri
without
glomerulonephr
vascul
arteriol
capillari
venul
convers
mpa
caus
necrot
vascul
immun
deposit
pauciimmun
affect
small
vessel
capillari
venul
arteriol
necrot
glomerulonephr
pulmonari
capillar
often
occur
mpa
typic
mpoanca
posit
sever
studi
explor
pathogen
process
paediatr
pan
mpa
pathogenesi
still
poorli
defin
like
mpa
somewhat
distinct
pan
term
pathogenesi
former
fall
categori
anca
associ
vascul
system
pan
cutan
pan
less
distinct
term
pathogenesi
howev
infecti
aetiolog
pan
consid
year
earli
observ
consid
streptococci
staphylococcu
aureu
like
candid
report
hepat
b
surfac
antigenaemia
immun
complex
format
associ
approxim
patient
pan
although
uk
rare
seen
children
virus
hepat
b
hepat
c
human
immunodefici
viru
hiv
cytomegaloviru
cmv
human
tcell
lymphotrop
parvoviru
report
etiolog
associ
pan
none
repeatedli
isol
patient
pan
anca
appear
play
signific
role
caus
endotheli
injuri
particularli
mpa
anca
present
minor
children
pan
howev
found
would
prompt
mani
clinician
consid
diagnosi
mpa
rather
classic
pan
said
paediatr
seri
approxim
patient
classic
pan
posit
panca
contrast
patient
mpa
posit
canca
antiproteinas
posit
panca
mpoanca
neg
anca
pathogen
mechan
like
involv
pan
exampl
superantigen
may
play
role
case
addit
associ
famili
mediterranean
fever
develop
pan
recogn
ethnic
group
recent
multicent
studi
pan
children
adolesc
report
polyarter
case
children
classifi
cutan
pan
pan
associ
hepat
b
surfac
antigen
hbsag
mpa
associ
anca
system
pan
patient
system
pan
multisystem
involv
usual
affect
skin
kidney
peripher
nerv
muscl
gastrointestin
tract
symptom
weight
loss
myalgia
pyrexia
common
contrast
cutan
pan
affect
skin
although
arthralgia
myalgia
occasion
associ
cutan
featur
pan
includ
system
predominantli
cutan
form
includ
ulcer
gangren
urticaria
livedo
racemosa
tender
pain
inflammatori
nodul
within
livedo
bulla
select
viscer
digit
subtract
arteriographi
dsa
still
play
import
role
diagnost
workup
children
suspect
pan
despit
suggest
noninvas
arteriographi
may
replac
dsa
clinic
situat
former
lack
sensit
subtl
chang
associ
smaller
order
vessel
seen
children
pan
recognis
magnet
reson
angiographi
overestim
vascular
stenot
lesion
brogan
et
al
describ
select
renal
dsa
find
children
system
pan
children
aneurysm
mostli
affect
small
mediums
arteri
presenc
significantli
associ
renal
impair
hypertens
nonaneurysm
chang
detect
commonli
renal
angiographi
aneurysm
pan
group
paediatr
randomis
control
trial
guid
therapi
pan
children
induct
remiss
system
pan
high
dose
corticosteroid
cyclophosphamid
latter
given
usual
iv
monthli
dose
month
combin
antiplatelet
dose
aspirin
adjunct
plasma
exchang
undoubtedli
still
play
import
role
children
gain
rapid
diseas
control
life
critic
organ
threaten
follow
success
induct
remiss
azathioprin
mgkg
day
institut
combin
low
dose
daili
altern
day
prednisolon
total
treatment
durat
minimum
month
usual
year
although
relaps
occur
mainten
phase
occur
much
less
commonli
vasculitid
wegen
granulomatosi
recent
success
treatment
system
pan
infliximab
rituximab
report
increasingli
use
biolog
treatment
pan
respond
convent
approach
describ
promis
preliminari
result
treatment
cutan
pan
typic
much
less
aggress
agent
commonli
utilis
includ
low
dose
prednisolon
antiplatelet
agent
colchicin
hydroxychloroquin
azathioprin
dapson
prefer
choic
author
risk
haemolyt
anaemia
use
cyclophosphamid
rare
justifi
cutan
pan
import
differenti
diagnosi
cutan
pan
children
adult
entiti
refer
occlus
vasculopathi
also
known
livedoid
vasculopathi
import
differenti
diagnosi
latter
respond
readili
antiplatelet
anticoagul
therapi
rather
immunosuppress
prognosi
individu
pan
vari
better
outcom
childhood
diseas
compar
adult
onset
diseas
mortal
rate
high
despit
aggress
therapi
recent
publish
mortal
pan
children
great
ormond
st
hospit
approxim
although
medium
term
prognosi
good
yet
clear
survivor
pan
childhood
prone
prematur
atherosclerosi
later
life
area
ongo
research
aav
occur
children
less
commonli
pan
dealt
detail
elsewher
edit
journal
follow
therefor
necessarili
brief
includ
wg
mpa
churgstrauss
syndrom
css
socal
renallimit
vascul
latter
probabl
variant
mpa
aav
children
share
mani
featur
adult
diseas
although
clearli
consequ
damag
caus
aav
renal
failur
import
differ
implic
grow
children
aav
occur
children
wg
mpa
seen
much
commonli
css
although
css
occur
children
clinic
featur
paediatr
diseas
recent
extens
describ
percept
children
wg
may
present
localis
diseas
adult
particularli
subglott
diseas
howev
anoth
rel
recent
larg
paediatr
seri
reveal
spectrum
diseas
present
intent
purpos
similar
adult
seri
localis
florid
multisystem
vasculit
present
describ
genet
contribut
aav
tabl
environment
factor
predispos
aav
like
similar
children
adult
discuss
elsewher
edit
journal
pathogenesi
paediatr
aav
also
recent
extens
review
elsewher
treatment
paediatr
aav
broadli
similar
approach
adult
corticosteroid
cyclophosphamid
plasma
exchang
particularli
pulmonari
capillar
andor
rapidli
progress
glomerulonephr
antiplatelet
dose
daili
aspirin
routin
employ
cotrimoxazol
routin
ad
treatment
wg
serv
prophylaxi
opportunist
infect
diseas
modifi
agent
newer
treatment
induct
remiss
aav
children
includ
mycophenol
mofetil
mmf
rituximab
first
time
children
includ
euva
trial
mmf
versu
cyclophosphamid
induct
remiss
aav
hope
provid
less
toxic
equal
effect
agent
replac
cyclophosphamid
futur
wwwvasculitisorg
increasingli
use
rituximab
children
wg
frequent
relaps
fail
respond
initi
convent
induct
therapi
result
promis
albeit
anecdot
paediatr
commun
yet
embrac
approach
protocol
rituximab
therapi
everi
six
month
irrespect
peripher
b
cell
return
wg
approach
begin
use
adult
vascul
treatment
protocol
despit
develop
newer
immunosuppress
agent
immunomodulatori
therapi
aav
still
carri
consider
diseas
relat
morbid
mortal
mainli
due
progress
renal
failur
aggress
respiratori
involv
flare
wg
occur
treatment
wean
signific
treatmentrel
infect
observ
approxim
signific
longterm
renal
impair
still
occur
mortal
paediatr
wg
one
recent
paediatr
seri
prognosi
mpa
children
similar
pan
term
mortal
albeit
higher
longterm
renal
morbid
relat
pauciimmun
crescent
nephriti
css
children
recent
seri
quot
rel
mortal
attribut
diseas
rather
therapi
takayasu
arter
ta
predominantli
larg
vessel
vascul
worldwid
distribut
although
diseas
common
asia
onset
ta
common
third
decad
life
park
et
al
report
seri
korean
patient
ta
year
age
year
old
onset
diseas
femal
affect
often
male
pathogenesi
ta
review
elsewher
journal
compar
limit
genet
associ
far
studi
may
associ
ta
summar
tabl
cakar
et
al
recent
report
seri
children
ta
common
complaint
present
headach
abdomin
pain
claudic
extrem
fever
weight
loss
one
child
present
visual
loss
examin
admiss
reveal
hypertens
absent
puls
arteri
bruit
convent
dsa
remain
import
tool
initi
evalu
paediatr
ta
increasingli
howev
magnet
reson
angiographi
mra
use
detect
earli
sign
largevessel
diseas
ad
advantag
potenti
reveal
evid
ongo
larg
arteri
wall
inflamm
one
caveat
howev
mra
may
result
fals
posit
diagnos
ta
base
aortic
sign
young
children
experi
two
preschool
children
refer
us
presumpt
diagnosi
ta
basi
aortic
calib
variat
observ
mra
turn
altern
diagnos
normal
aortic
anatomi
subsequ
formal
digit
subtract
arteriographi
cakar
seri
angiographi
reveal
stenosi
common
type
lesion
follow
occlus
dilat
aneurysm
commonli
involv
vessel
renal
subclavian
carotid
arteri
whilst
previou
seri
report
innomin
subclavian
arteri
case
follow
aorta
frequent
involv
vessel
positron
emiss
tomographi
pet
scan
radioactivelabel
fdg
shown
use
monitor
diseas
activ
respons
treatment
preliminari
studi
presenc
absenc
fdg
uptak
correl
well
clinic
state
mra
find
term
therapi
adult
ta
progress
hamper
lack
good
clinic
trial
base
firm
recommend
corticosteroid
still
mainstay
treatment
ta
addit
mtx
azathioprin
mmf
cyclophosphamid
use
children
cyclophosphamid
use
children
sever
ta
refractori
immunosuppress
drug
ozen
et
al
describ
children
ta
treatment
steroid
cyclophosphamid
induct
follow
mtx
suggest
effect
safe
childhood
ta
widespread
diseas
antitnf
therapi
might
benefici
ta
high
rate
respons
tnf
inhibitor
report
import
topic
consid
detail
elsewher
journal
besid
medic
therapi
surgic
intervent
frequent
requir
allevi
endorgan
ischemia
hypertens
result
vascular
stenos
primari
system
vasculitid
rel
rare
condit
children
carri
signific
morbid
mortal
despit
newer
diagnost
modal
treatment
understand
diseas
pathogenesi
advanc
still
much
learn
signific
short
longterm
challeng
loom
includ
establish
intern
research
network
databas
obtain
adequ
patient
number
enabl
power
paediatr
studi
valid
classif
criteria
suitabl
paediatr
vasculitid
current
underway
develop
tool
biomark
allow
reliabl
noninvas
monitor
diseas
activ
develop
robust
core
outcom
variabl
use
assess
outcom
clinic
trial
lastli
remain
question
regard
longer
term
cardiovascular
morbid
children
surviv
vascul
ultim
must
anticip
advanc
understand
environment
trigger
host
respons
shape
futur
novel
therapeut
approach
psv
young
author
declar
conflict
interest
develop
clinic
outcom
variabl
biomark
allow
reliabl
noninvas
monitor
diseas
activ
advanc
understand
environment
trigger
host
respons
result
vascul
young
optimis
current
vascul
treatment
protocol
develop
novel
therapeut
approach
investig
longer
term
cardiovascular
morbid
children
surviv
vascul
